What's new in steroid receptor immunocytochemistry in clinical oncology?
1Department of Clinical Oncology, St. Georges Medical School, London, England.
Pathology, Research and Practice
|December 1, 1989
Abstract:
In this review we outline the many practical advantages of immunocytochemistry for estrogen receptors (ER) and the staining intensity index for its interpretation. We discuss the heterogenous distribution of ER in malignant and non-malignant breast tissue and the correlation of ER staining with pathologic features. In predicting the response of breast cancer to endocrine therapy, we conclude that both fine needle aspirates and tissue sections are adequate for the assessment of ER.
More Related Videos
Related Concept Videos
01:22Immunocytochemistry and Immunohistochemistry
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
These...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.